Novelcare
Novelcare is an artificial intelligence company founded in 2022 [12] headquartered in New York City, NY, USA with remote operations [1]. The company was accepted into Y Combinator's Winter 2023 batch [2]. Novelcare addresses patient recruitment in clinical trials by analyzing electronic health records to help doctors identify clinical trials for their patients and assist trial sites in locating suitable study participants [5]. According to the company's stated mission, 72% of doctors want to inform their patients of clinical trials, but only 5% do [5]. The company operates with a team of five employees [13] and is listed among AI companies in the New York startup ecosystem [3].
Key people
About
- Novelcare addresses the primary bottleneck in drug development: recruiting patients into clinical trials. We analyze electronic health records to help doctors find clinical trials for their patients, and to help trial sites find patients for their studies. 72% of doctors want to inform their patients of clinical trials, but only 5% do. We're on a mission to close that gap, ultimately bringing safer, more effective drugs to the patients who need them.[5]
- Novelcare addresses the primary bottleneck in drug development: recruiting patients into clinical trials. We analyze electronic health records to help doctors find clinical trials for their patients, and to help trial sites find patients for their studies. 72% of doctors want to inform their patients of clinical trials, but only 5% do. We're on a mission to close that gap, ultimately bringing safer, more effective drugs to the patients who need them.[9]
Something wrong or missing? Send a correction. Fixed within 24 hours.